PMID- 21365257 OWN - NLM STAT- MEDLINE DCOM- 20120316 LR - 20211020 IS - 2629-3277 (Electronic) IS - 2629-3277 (Linking) VI - 7 IP - 4 DP - 2011 Nov TI - A comparison of stem cells for therapeutic use. PG - 782-96 LID - 10.1007/s12015-011-9241-y [doi] AB - A critical comparison of the attributes of several types of stem cells is presented, with particular emphasis on properties that are critical for the application of these cells for therapeutic purposes. The importance of an autologous source of pluripotent stem cells is stressed. It is apparent that two sources currently exist for non-embryonic pluripotent stem cells--very small embryonic-like stem cells (VSELs) and induced pluripotent stem cells (iPS). The impact of the emerging iPS research on therapy is considered. FAU - Rodgerson, Denis O AU - Rodgerson DO AD - NeoStem, Inc., 420 Lexington Avenue, Suite 450, New York, NY 10170, USA. drodgerson@neostem.com FAU - Harris, Alan G AU - Harris AG LA - eng GR - R43 AR056893-01A1/AR/NIAMS NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Review PL - United States TA - Stem Cell Rev Rep JT - Stem cell reviews and reports JID - 101752767 RN - 0 (Genetic Markers) SB - IM EIN - Stem Cell Rev. 2012 Jun;8(2):547 MH - Animals MH - Cell Culture Techniques MH - Cell Differentiation MH - Cell Movement MH - Embryonic Stem Cells/*cytology/physiology MH - Epigenesis, Genetic MH - Genetic Markers MH - Hematopoietic Stem Cells/cytology/physiology MH - Humans MH - Induced Pluripotent Stem Cells/*cytology/physiology/transplantation MH - Mice MH - *Regeneration MH - Stem Cell Research MH - Stem Cell Transplantation EDAT- 2011/03/03 06:00 MHDA- 2012/03/17 06:00 CRDT- 2011/03/03 06:00 PHST- 2011/03/03 06:00 [entrez] PHST- 2011/03/03 06:00 [pubmed] PHST- 2012/03/17 06:00 [medline] AID - 10.1007/s12015-011-9241-y [doi] PST - ppublish SO - Stem Cell Rev Rep. 2011 Nov;7(4):782-96. doi: 10.1007/s12015-011-9241-y.